These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 33068904)

  • 1. Matrix metalloproteinases deregulation in amyotrophic lateral sclerosis.
    Sánchez-Torres JL; Yescas-Gómez P; Torres-Romero J; Espinosa OR; Canovas LL; Tecalco-Cruz ÁC; Ponce-Regalado MD; Alvarez-Sánchez ME
    J Neurol Sci; 2020 Dec; 419():117175. PubMed ID: 33068904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in amyotrophic lateral sclerosis (ALS).
    Łukaszewicz-Zając M; Mroczko B; Słowik A
    J Neural Transm (Vienna); 2014 Nov; 121(11):1387-97. PubMed ID: 25047909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix metalloproteinases and their tissue inhibitors in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
    Niebroj-Dobosz I; Janik P; Sokołowska B; Kwiecinski H
    Eur J Neurol; 2010 Feb; 17(2):226-31. PubMed ID: 19796283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MyomiRs and their multifaceted regulatory roles in muscle homeostasis and amyotrophic lateral sclerosis.
    Giagnorio E; Malacarne C; Mantegazza R; Bonanno S; Marcuzzo S
    J Cell Sci; 2021 Jun; 134(12):. PubMed ID: 34137441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of matrix metalloproteinases in serum of patients with amyotrophic lateral sclerosis with pattern recognition methods.
    Sokolowska B; Jozwik A; Niebroj-Dobosz I; Janik P; Kwiecinski H
    J Physiol Pharmacol; 2009 Nov; 60 Suppl 5():117-20. PubMed ID: 20134051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue inhibitors of matrix metalloproteinases are elevated in cerebrospinal fluid of neurodegenerative diseases.
    Lorenzl S; Albers DS; LeWitt PA; Chirichigno JW; Hilgenberg SL; Cudkowicz ME; Beal MF
    J Neurol Sci; 2003 Mar; 207(1-2):71-6. PubMed ID: 12614934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Linking neuron and skin: matrix metalloproteinases in amyotrophic lateral sclerosis (ALS).
    Fang L; Huber-Abel F; Teuchert M; Hendrich C; Dorst J; Schattauer D; Zettlmeissel H; Wlaschek M; Scharffetter-Kochanek K; Tumani H; Ludolph AC; Brettschneider J
    J Neurol Sci; 2009 Oct; 285(1-2):62-6. PubMed ID: 19523650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in genetics research in the pathogenesis of amyotrophic lateral sclerosis.
    Wang Y; Yi H; Liao Q; Bi F
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 Dec; 45(12):1483-1489. PubMed ID: 33473007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multifaceted Role of Matrix Metalloproteinases in Neurodegenerative Diseases: Pathophysiological and Therapeutic Perspectives.
    Behl T; Kaur G; Sehgal A; Bhardwaj S; Singh S; Buhas C; Judea-Pusta C; Uivarosan D; Munteanu MA; Bungau S
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33573368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Muscle histone deacetylase 4 upregulation in amyotrophic lateral sclerosis: potential role in reinnervation ability and disease progression.
    Bruneteau G; Simonet T; Bauché S; Mandjee N; Malfatti E; Girard E; Tanguy ML; Behin A; Khiami F; Sariali E; Hell-Remy C; Salachas F; Pradat PF; Fournier E; Lacomblez L; Koenig J; Romero NB; Fontaine B; Meininger V; Schaeffer L; Hantaï D
    Brain; 2013 Aug; 136(Pt 8):2359-68. PubMed ID: 23824486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNAs in amyotrophic lateral sclerosis: from pathogenetic involvement to diagnostic biomarker and therapeutic agent development.
    Wang L; Zhang L
    Neurol Sci; 2020 Dec; 41(12):3569-3577. PubMed ID: 33006054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Friends or Foes: Matrix Metalloproteinases and Their Multifaceted Roles in Neurodegenerative Diseases.
    Brkic M; Balusu S; Libert C; Vandenbroucke RE
    Mediators Inflamm; 2015; 2015():620581. PubMed ID: 26538832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metalloproteinase alterations in the bone marrow of ALS patients.
    Bossolasco P; Cova L; Calzarossa C; Servida F; Mencacci NE; Onida F; Polli E; Lambertenghi Deliliers G; Silani V
    J Mol Med (Berl); 2010 Jun; 88(6):553-64. PubMed ID: 20091292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The matrix metalloproteinases inhibitor Ro 28-2653 [correction of Ro 26-2853] extends survival in transgenic ALS mice.
    Lorenzl S; Narr S; Angele B; Krell HW; Gregorio J; Kiaei M; Pfister HW; Beal MF
    Exp Neurol; 2006 Jul; 200(1):166-71. PubMed ID: 16516196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purinergic P2X
    Mckenzie ADJ; Garrett TR; Werry EL; Kassiou M
    ACS Chem Neurosci; 2022 May; 13(10):1479-1490. PubMed ID: 35512313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matrix metalloproteinases and their tissue inhibitors as markers of disease subtype and response to interferon-beta therapy in relapsing and secondary-progressive multiple sclerosis patients.
    Galboiz Y; Shapiro S; Lahat N; Rawashdeh H; Miller A
    Ann Neurol; 2001 Oct; 50(4):443-51. PubMed ID: 11601495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delayed disease onset and extended survival in the SOD1G93A rat model of amyotrophic lateral sclerosis after suppression of mutant SOD1 in the motor cortex.
    Thomsen GM; Gowing G; Latter J; Chen M; Vit JP; Staggenborg K; Avalos P; Alkaslasi M; Ferraiuolo L; Likhite S; Kaspar BK; Svendsen CN
    J Neurosci; 2014 Nov; 34(47):15587-600. PubMed ID: 25411487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospects for gene replacement therapies in amyotrophic lateral sclerosis.
    Giovannelli I; Higginbottom A; Kirby J; Azzouz M; Shaw PJ
    Nat Rev Neurol; 2023 Jan; 19(1):39-52. PubMed ID: 36481799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Matrix metalloproteinases in the neocortex and spinal cord of amyotrophic lateral sclerosis patients.
    Lim GP; Backstrom JR; Cullen MJ; Miller CA; Atkinson RD; Tökés ZA
    J Neurochem; 1996 Jul; 67(1):251-9. PubMed ID: 8666998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Consideration of gravity as a possible etiological factor in amyotrophic lateral sclerosis.
    Akaishi T; Takahashi T; Abe M; Aoki M; Ishii T
    Med Hypotheses; 2019 Nov; 132():109369. PubMed ID: 31442918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.